ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,378 | -30.9% | 450 | -20.6% | 0.00% | – |
| Q2 2023 | $13,580 | +621.6% | 567 | +467.0% | 0.00% | – |
| Q1 2023 | $1,882 | +18.2% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $1,592 | -20.4% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -100.0% | 100 | -99.3% | 0.00% | -100.0% |
| Q1 2021 | $380,292,000 | +4225366.7% | 14,740 | +8322.9% | 0.00% | – |
| Q4 2020 | $9,000 | +28.6% | 175 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | +75.0% | 175 | +133.3% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 75 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -92.9% | 75 | -95.3% | 0.00% | -100.0% |
| Q2 2019 | $42,000 | -22.2% | 1,600 | -38.5% | 0.00% | -33.3% |
| Q3 2018 | $54,000 | -48.6% | 2,600 | -62.3% | 0.00% | -50.0% |
| Q2 2018 | $105,000 | -33.1% | 6,900 | -1.4% | 0.01% | -45.5% |
| Q1 2018 | $157,000 | -21.5% | 7,000 | +5.3% | 0.01% | -26.7% |
| Q4 2017 | $200,000 | – | 6,650 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |